Stockscreener 앱 받기
2.45
5.62%
-0.13
전일 마감가:
$2.58
열려 있는:
$2.55
하루 거래량:
986.11K
Relative Volume:
0.46
시가총액:
$369.10M
수익:
$12.87M
순이익/손실:
$-114.34M
주가수익비율:
-2.8337
EPS:
-0.8646
순현금흐름:
$-79.23M
1주 성능:
+35.28%
1개월 성능:
+99.59%
6개월 성능:
+91.73%
1년 성능:
-5.25%
1일 변동 폭
$2.435
$2.565
1주일 범위
$1.755
$2.725
52주 변동 폭
$1.05
$4.32
Taysha Gene Therapies Inc Stock (TSHA) Company Profile
명칭
Taysha Gene Therapies Inc
전화
(214) 612-0000
주소
3000 PEGASUS PARK DRIVE, DALLAS
TSHA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TSHA
Taysha Gene Therapies Inc
|
2.45 | 369.10M | 12.87M | -114.34M | -79.23M | -0.8646 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.89 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
606.30 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
654.90 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.99 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
252.57 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-27 | 개시 | BMO Capital Markets | Outperform |
| 2024-04-09 | 개시 | Piper Sandler | Overweight |
| 2023-02-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-01-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-03-09 | 개시 | Robert W. Baird | Outperform |
| 2022-03-01 | 개시 | Wells Fargo | Overweight |
| 2022-02-18 | 개시 | SMBC Nikko | Outperform |
| 2021-12-16 | 개시 | Guggenheim | Buy |
| 2021-07-16 | 개시 | Needham | Buy |
| 2021-06-24 | 개시 | Truist | Buy |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-06-09 | 개시 | Wedbush | Outperform |
| 2021-06-08 | 개시 | JMP Securities | Mkt Outperform |
| 2021-05-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-05-11 | 재개 | Jefferies | Buy |
| 2021-02-24 | 개시 | William Blair | Outperform |
| 2021-01-05 | 개시 | Oppenheimer | Outperform |
| 2020-10-19 | 개시 | Chardan Capital Markets | Buy |
| 2020-10-19 | 개시 | Goldman | Buy |
| 2020-10-19 | 개시 | Jefferies | Buy |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
모두보기
Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스
Taysha Gene Therapies (NASDAQ:TSHA) Trading Up 9.3% – Should You Buy? - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Consensus Price Target from Analysts - Defense World
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Taysha Gene Therapies (TSHA) Grants Employee Stock Option Under Inducement Plan | TSHA Stock News - GuruFocus
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus
BMO Capital Markets slashes price target on Taysha Gene Therapies Inc [TSHA] – find out why. - dbtnews.com
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Taysha Gene Therapies Grants $108,450 Stock Option Package: New Executive Compensation Details Revealed - Stock Titan
Taysha Gene Therapies (TSHA) Gains Analyst Support with Promisin - GuruFocus
Buying Buzz: Taysha Gene Therapies Inc [TSHA] 10% Owner Manning Paul B purchases 1,333,333 shares of the company – Knox Daily - knoxdaily.com
Anchoring Your Portfolio: Is TSHA Stock a Safe Harbor? - investchronicle.com
60,000 Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Bought by LPL Financial LLC - Defense World
Gaining Ground: Taysha Gene Therapies Inc (TSHA) Closes Higher at 1.82, Up 1.11 - DWinneX
What is Taysha Gene Therapies Inc (TSHA) Stock Return on Shareholders’ Capital? - Sete News
Taysha Gene Therapies’ (TSHA) Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World
Taysha Gene Therapies (NASDAQ:TSHA) Receives Market Outperform Rating from JMP Securities - Defense World
Understanding the Risks of Investing in Taysha Gene Therapies Inc (TSHA) - knoxdaily.com
Examining TSHA’s book value per share for the latest quarter - uspostnews.com
Taysha Gene Therapies Inc (NASDAQ: TSHA) Prices Could Soar To Much Higher Levels In Coming Months - Marketing Sentinel
Geode Capital Management LLC Has $6.18 Million Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies Inc (TSHA) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Keeping an Eye on Taysha Gene Therapies Inc (TSHA) After Insider Trading Activity - knoxdaily.com
Taysha Gene Therapies Inc [TSHA] stock Initiated by BMO Capital Markets analyst, price target now $5 - dbtnews.com
Discover Fractyl Health And 2 More Promising Penny Stocks - simplywall.st
What is going on with Taysha Gene Therapies Inc? Sentiment Analysis - uspostnews.com
How Will Taysha Gene Therapies Inc (NASDAQ: TSHA) Perform In Months To Come? - Marketing Sentinel
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by JPMorgan Chase & Co. - Defense World
Vanguard Group Inc. Raises Stock Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies: Sell Rating On Uncertain Pipeline Prospects And Limited Opportunity - Seeking Alpha
Wellington Management Group LLP Raises Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Commonwealth Equity Services LLC Purchases 31,000 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Taysha Gene Therapies (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Rating of “Buy” from Brokerages - The AM Reporter
AskBio Elects Dr. Laura Sepp-Lorenzino Independent Member of Board of Directors - The Manila Times
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Consensus Target Price from Brokerages - Defense World
Taysha Expands Team: 822,000 Stock Options Awarded in Strategic Growth Move - Stock Titan
At $1.32 Price, Taysha Gene Therapies Inc (TSHA) Is Sitting And Waiting - stocksregister.com
Wall Street Was Disappointed By Taysha Gene Therapies Inc (NASDAQ: TSHA)’s -3.96% Stock Price Decline - Marketing Sentinel
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet - Benzinga
Taysha Stock Hits 52-Week Low at $1.17 Amid Challenges By Investing.com - Investing.com South Africa
Taysha Stock Hits 52-Week Low at $1.17 Amid Challenges - Investing.com
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Taysha Gene Therapies Inc (NASDAQ: TSHA) Is Up 33.89% From Its 52-Week Low; YTD, It Is Up 4.05% – What To Do Now – Marketing Sentinel - Marketing Sentinel
Bank of New York Mellon Corp Acquires 111,989 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Is Taysha Gene Therapies (TSHA) the Best Short Squeeze Stock to Buy According to Analysts? - Insider Monkey
10 Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey
Taysha Gene Therapies (TSHA) Projected to Post Earnings on Tuesday - The AM Reporter
Analysts Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.63 - Defense World
Taysha Gene Therapies’ SWOT analysis: stock’s potential in Rett syndrome treatment By Investing.com - Investing.com South Africa
Taysha Gene Therapies Inc (TSHA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.58%
0.47%
자본화:
|
볼륨(24시간):